Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quality assurance and safety of hippocampal avoidance prophylactic cranial irradiation in the multicenter randomized phase III trial (NCT01780675).
Candiff O, Belderbos J, Wolf AL, Damen E, van Haaren P, Crijns W, Hol S, Paelinck L, van Kesteren Z, Jaspers J, de Kerf G, van Elmpt W, Ubbels F, Schagen S, de Ruysscher D, de Ruiter M. Candiff O, et al. Among authors: damen e. J Natl Cancer Cent. 2023 May 19;3(2):135-140. doi: 10.1016/j.jncc.2023.05.004. eCollection 2023 Jun. J Natl Cancer Cent. 2023. PMID: 39035727 Free PMC article.
The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer.
van Elmpt W, De Ruysscher D, van der Salm A, Lakeman A, van der Stoep J, Emans D, Damen E, Öllers M, Sonke JJ, Belderbos J. van Elmpt W, et al. Among authors: damen e. Radiother Oncol. 2012 Jul;104(1):67-71. doi: 10.1016/j.radonc.2012.03.005. Epub 2012 Apr 6. Radiother Oncol. 2012. PMID: 22483675 Clinical Trial.
The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial).
van Diessen J, De Ruysscher D, Sonke JJ, Damen E, Sikorska K, Reymen B, van Elmpt W, Westman G, Fredberg Persson G, Dieleman E, Bjorkestrand H, Faivre-Finn C, Belderbos J. van Diessen J, et al. Among authors: damen e. Radiother Oncol. 2019 Feb;131:166-173. doi: 10.1016/j.radonc.2018.09.019. Epub 2018 Oct 13. Radiother Oncol. 2019. PMID: 30327236 Clinical Trial.
18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial.
Cooke SA, de Ruysscher D, Reymen B, Lambrecht M, Fredberg Persson G, Faivre-Finn C, Dieleman EMT, Lewensohn R, van Diessen JNA, Sikorska K, Lalezari F, Vogel W, van Elmpt W, Damen EMF, Sonke JJ, Belderbos JSA. Cooke SA, et al. Among authors: damen emf. Radiother Oncol. 2023 Apr;181:109492. doi: 10.1016/j.radonc.2023.109492. Epub 2023 Jan 24. Radiother Oncol. 2023. PMID: 36706958 Clinical Trial.
Pareto fronts in clinical practice for pinnacle.
Janssen T, van Kesteren Z, Franssen G, Damen E, van Vliet C. Janssen T, et al. Among authors: damen e. Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):873-80. doi: 10.1016/j.ijrobp.2012.05.045. Epub 2012 Aug 15. Int J Radiat Oncol Biol Phys. 2013. PMID: 22901383
92 results